Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency by Seini Moimoi | Jul 2, 2024 | Portfolio News
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASG12D-Selective Dual-State Allosteric Inhibitor, and Other Program Updates by Seini Moimoi | Jun 27, 2024 | Portfolio News
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes by Seini Moimoi | Jun 25, 2024 | Portfolio News
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec by Seini Moimoi | Jun 18, 2024 | Portfolio News
Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies by Seini Moimoi | Jun 17, 2024 | Portfolio News
